These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 11781834

  • 1. Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells.
    Schwarze SR, Shi Y, Fu VX, Watson PA, Jarrard DF.
    Oncogene; 2001 Dec 13; 20(57):8184-92. PubMed ID: 11781834
    [Abstract] [Full Text] [Related]

  • 2. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells.
    Jarrard DF, Sarkar S, Shi Y, Yeager TR, Magrane G, Kinoshita H, Nassif N, Meisner L, Newton MA, Waldman FM, Reznikoff CA.
    Cancer Res; 1999 Jun 15; 59(12):2957-64. PubMed ID: 10383161
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Involvement of the Ink4 proteins p16 and p15 in T-lymphocyte senescence.
    Erickson S, Sangfelt O, Heyman M, Castro J, Einhorn S, Grandér D.
    Oncogene; 1998 Aug 06; 17(5):595-602. PubMed ID: 9704925
    [Abstract] [Full Text] [Related]

  • 8. Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence.
    Xin H, Curry J, Johnstone RW, Nickoloff BJ, Choubey D.
    Oncogene; 2003 Jul 31; 22(31):4831-40. PubMed ID: 12894224
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CDK2 translational down-regulation during endothelial senescence.
    Freedman DA, Folkman J.
    Exp Cell Res; 2005 Jul 01; 307(1):118-30. PubMed ID: 15922732
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
    Untergasser G, Gander R, Lilg C, Lepperdinger G, Plas E, Berger P.
    Mech Ageing Dev; 2005 Jan 01; 126(1):59-69. PubMed ID: 15610763
    [Abstract] [Full Text] [Related]

  • 19. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells.
    Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, Boilly-Marer Y.
    J Cell Biochem; 1999 Sep 01; 74(3):486-98. PubMed ID: 10412049
    [Abstract] [Full Text] [Related]

  • 20. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S, Lowe M, Herliczek TW, Keyomarsi K.
    Oncogene; 1998 Nov 05; 17(18):2393-402. PubMed ID: 9811471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.